Impact of Initial Cardiology Telemedicine Evaluation on Follow-Up Visits for Common Conditions: Quasi-Experimental Study

TL;DR

This study finds that initial telemedicine evaluations in cardiology lead to more follow-up visits for some conditions but fewer for others.

Contribution

The study provides new evidence on how initial telemedicine evaluations affect follow-up visit rates for specific cardiovascular conditions.

Findings

Telemedicine initial evaluations increased follow-up visits for symptomatic conditions like syncope or dizziness.

For chronic conditions like coronary artery disease, telemedicine initial evaluations decreased follow-up visits.

The effect of telemedicine varied significantly depending on the patient's presenting condition.

Abstract

Telemedicine use has increased significantly in cardiology clinics, but the impact of initial telemedicine evaluation on total visit usage is unknown.

This study aimed to determine the effect of initial telemedicine evaluation on the number of follow-up visits within 6 months for common cardiovascular conditions at an academic health system.

Electronic health records data were extracted for general cardiology visits. New patient visits (NPVs) were included occurring from June 1, 2020, to May 31, 2023, for 10 common cardiovascular conditions—atrial fibrillation or flutter, chest pain, coronary artery disease, dyslipidemia, dyspnea, heart failure, hypertension, palpitations, preoperative evaluation, and syncope or dizziness. The effect of initial telemedicine versus in-person evaluation on follow-up visits within 6 months was assessed using a 2-stage least squares instrumental variable model with the proportion of clinician telemedicine use as the instrument and adjustment for patient and visit characteristics.

There were 5528 NPVs conducted by 40 general cardiology clinicians during the study period. The average patient age was 56 (SD 17.5) years, 54.2% (2998/5528) were female, 43.2% (2389/5528) were non-Hispanic White, 24.7% (1368/5528) were Asian, 13.8% (761/5528) were Hispanic, 34.4% (1904/5528) were on Medicare, and 13.2% (729/5528) were on Medicaid. Of the NPVs, 53.5% (2959/5528) were conducted via telemedicine (2814/5528, 50.9% via video and 145/5528, 2.6% via phone). Telemedicine use for NPVs ranged from 0% to 100% (N=40) across individual clinicians. The average number of follow-up visits was 57 visits per 100 patients within 6 months across all diagnosis groups. Patients receiving telemedicine NPVs were more likely to have telemedicine follow-up visits than those receiving in-person NPVs (1354/1619, 83.6% vs 680/1533, 44.4%). In the instrumental variable analysis, the impact of initial telemedicine evaluation differed by presenting condition. There was an increase in follow-up visits for patients with syncope or dizziness (29.8 visits/100 patients, 95% CI 6.4-53.1), palpitations (34.9 visits/100 patients, 95% CI 18.6-51.1), chest pain (36.9 visits/100 patients, 95% CI 18.5-55.2), and dyspnea (37.0 visits/100 patients, 95% CI 11.8-62.0). There was a decrease in follow-up visits for patients with coronary artery disease (−29.5 visits/100 patients, 95% CI −50.3 to −8.6) and dyslipidemia (−24.5 visits/100 patients, 95% CI −40.2 to −8.8). There was no significant effect for patients presenting for atrial fibrillation or flutter, heart failure, hypertension, and preoperative evaluation.

The effect of initial telemedicine evaluation on follow-up visits varied significantly by presenting condition in this cardiology practice. Telemedicine use resulted in increased follow-up visits for patients presenting with symptomatic complaints, while for those presenting with chronic conditions, there was no significant effect or a decrease in visits. Future studies should assess strategies to target initial care modalities to appropriate patients in cardiology clinics with early in-person evaluation for symptomatic patients.

Figures